GO:0003747 | translation release factor activity | 8.52e-06 | 8.32e-02 | 8.395 | 2 | 2 | 2 |
GO:0042754 | negative regulation of circadian rhythm | 1.27e-04 | 1.00e+00 | 6.810 | 2 | 2 | 6 |
GO:0006479 | protein methylation | 4.61e-04 | 1.00e+00 | 5.936 | 2 | 2 | 11 |
GO:0005654 | nucleoplasm | 6.95e-04 | 1.00e+00 | 1.791 | 9 | 68 | 876 |
GO:0046966 | thyroid hormone receptor binding | 1.57e-03 | 1.00e+00 | 5.073 | 2 | 3 | 20 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 2.45e-03 | 1.00e+00 | 4.752 | 2 | 3 | 25 |
GO:0005525 | GTP binding | 2.57e-03 | 1.00e+00 | 2.773 | 4 | 12 | 197 |
GO:0001607 | neuromedin U receptor activity | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0004832 | valine-tRNA ligase activity | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0016300 | tRNA (uracil) methyltransferase activity | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0000939 | condensed chromosome inner kinetochore | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0042924 | neuromedin U binding | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0019153 | protein-disulfide reductase (glutathione) activity | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0016149 | translation release factor activity, codon specific | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0052565 | response to defense-related host nitric oxide production | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 2.97e-03 | 1.00e+00 | 8.395 | 1 | 1 | 1 |
GO:0005778 | peroxisomal membrane | 3.29e-03 | 1.00e+00 | 4.537 | 2 | 3 | 29 |
GO:0010467 | gene expression | 4.24e-03 | 1.00e+00 | 1.917 | 6 | 49 | 535 |
GO:0048511 | rhythmic process | 5.60e-03 | 1.00e+00 | 4.147 | 2 | 5 | 38 |
GO:0003723 | RNA binding | 5.77e-03 | 1.00e+00 | 2.447 | 4 | 22 | 247 |
GO:0008074 | guanylate cyclase complex, soluble | 5.93e-03 | 1.00e+00 | 7.395 | 1 | 1 | 2 |
GO:0002023 | reduction of food intake in response to dietary excess | 5.93e-03 | 1.00e+00 | 7.395 | 1 | 1 | 2 |
GO:0008611 | ether lipid biosynthetic process | 5.93e-03 | 1.00e+00 | 7.395 | 1 | 1 | 2 |
GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling | 5.93e-03 | 1.00e+00 | 7.395 | 1 | 1 | 2 |
GO:0000775 | chromosome, centromeric region | 6.50e-03 | 1.00e+00 | 4.038 | 2 | 6 | 41 |
GO:0006406 | mRNA export from nucleus | 7.46e-03 | 1.00e+00 | 3.936 | 2 | 7 | 44 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 8.88e-03 | 1.00e+00 | 6.810 | 1 | 1 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 8.88e-03 | 1.00e+00 | 6.810 | 1 | 1 | 3 |
GO:0000778 | condensed nuclear chromosome kinetochore | 8.88e-03 | 1.00e+00 | 6.810 | 1 | 2 | 3 |
GO:0002098 | tRNA wobble uridine modification | 8.88e-03 | 1.00e+00 | 6.810 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 8.88e-03 | 1.00e+00 | 6.810 | 1 | 1 | 3 |
GO:0040019 | positive regulation of embryonic development | 8.88e-03 | 1.00e+00 | 6.810 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 8.88e-03 | 1.00e+00 | 6.810 | 1 | 1 | 3 |
GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly | 8.88e-03 | 1.00e+00 | 6.810 | 1 | 1 | 3 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 8.88e-03 | 1.00e+00 | 6.810 | 1 | 1 | 3 |
GO:0097452 | GAIT complex | 1.18e-02 | 1.00e+00 | 6.395 | 1 | 2 | 4 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 1.18e-02 | 1.00e+00 | 6.395 | 1 | 1 | 4 |
GO:0006449 | regulation of translational termination | 1.18e-02 | 1.00e+00 | 6.395 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 1.18e-02 | 1.00e+00 | 6.395 | 1 | 2 | 4 |
GO:0006333 | chromatin assembly or disassembly | 1.18e-02 | 1.00e+00 | 6.395 | 1 | 1 | 4 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 1.18e-02 | 1.00e+00 | 6.395 | 1 | 1 | 4 |
GO:0008380 | RNA splicing | 1.25e-02 | 1.00e+00 | 2.614 | 3 | 21 | 165 |
GO:0042826 | histone deacetylase binding | 1.27e-02 | 1.00e+00 | 3.537 | 2 | 5 | 58 |
GO:0000785 | chromatin | 1.31e-02 | 1.00e+00 | 3.513 | 2 | 6 | 59 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 3 | 5 |
GO:0008610 | lipid biosynthetic process | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 1 | 5 |
GO:0000127 | transcription factor TFIIIC complex | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 3 | 5 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 3 | 5 |
GO:0060087 | relaxation of vascular smooth muscle | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 1 | 5 |
GO:0004521 | endoribonuclease activity | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 1 | 5 |
GO:0005229 | intracellular calcium activated chloride channel activity | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 1 | 5 |
GO:0042382 | paraspeckles | 1.48e-02 | 1.00e+00 | 6.073 | 1 | 3 | 5 |
GO:0000166 | nucleotide binding | 1.49e-02 | 1.00e+00 | 2.521 | 3 | 13 | 176 |
GO:0006415 | translational termination | 1.49e-02 | 1.00e+00 | 3.418 | 2 | 2 | 63 |
GO:0050847 | progesterone receptor signaling pathway | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 1 | 6 |
GO:0004383 | guanylate cyclase activity | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 1 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 2 | 6 |
GO:0001649 | osteoblast differentiation | 2.02e-02 | 1.00e+00 | 3.186 | 2 | 5 | 74 |
GO:0002199 | zona pellucida receptor complex | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 4 | 7 |
GO:0007140 | male meiosis | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 1 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 2 | 7 |
GO:0007617 | mating behavior | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 1 | 7 |
GO:0048016 | inositol phosphate-mediated signaling | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 1 | 7 |
GO:0051382 | kinetochore assembly | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 2 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 2 | 7 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 2 | 7 |
GO:0042340 | keratan sulfate catabolic process | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 1 | 7 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 4 | 7 |
GO:0016020 | membrane | 2.11e-02 | 1.00e+00 | 1.158 | 8 | 56 | 1207 |
GO:0006878 | cellular copper ion homeostasis | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 1 | 8 |
GO:0071949 | FAD binding | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 4 | 8 |
GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 1 | 8 |
GO:0004535 | poly(A)-specific ribonuclease activity | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 1 | 8 |
GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 1 | 8 |
GO:0006940 | regulation of smooth muscle contraction | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 1 | 8 |
GO:0050482 | arachidonic acid secretion | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 1 | 8 |
GO:0030529 | ribonucleoprotein complex | 2.44e-02 | 1.00e+00 | 3.038 | 2 | 5 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.55e-02 | 1.00e+00 | 3.003 | 2 | 5 | 84 |
GO:0030488 | tRNA methylation | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 1 | 9 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 2 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 3 | 9 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 1 | 9 |
GO:0007625 | grooming behavior | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 1 | 9 |
GO:0044822 | poly(A) RNA binding | 2.75e-02 | 1.00e+00 | 1.338 | 6 | 45 | 799 |
GO:0001967 | suckling behavior | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 4 | 10 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 2 | 10 |
GO:0042974 | retinoic acid receptor binding | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 1 | 10 |
GO:0018146 | keratan sulfate biosynthetic process | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 1 | 10 |
GO:0005095 | GTPase inhibitor activity | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 1 | 10 |
GO:0006182 | cGMP biosynthetic process | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 1 | 10 |
GO:0008143 | poly(A) binding | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 2 | 10 |
GO:0030014 | CCR4-NOT complex | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 1 | 10 |
GO:0008201 | heparin binding | 2.96e-02 | 1.00e+00 | 2.888 | 2 | 4 | 91 |
GO:0042809 | vitamin D receptor binding | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 2 | 11 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 4 | 11 |
GO:2000036 | regulation of stem cell maintenance | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 1 | 11 |
GO:0007263 | nitric oxide mediated signal transduction | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 1 | 12 |
GO:0000132 | establishment of mitotic spindle orientation | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 2 | 12 |
GO:0042339 | keratan sulfate metabolic process | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 1 | 13 |
GO:0043393 | regulation of protein binding | 4.08e-02 | 1.00e+00 | 4.588 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 4.08e-02 | 1.00e+00 | 4.588 | 1 | 2 | 14 |
GO:0005739 | mitochondrion | 4.25e-02 | 1.00e+00 | 1.353 | 5 | 32 | 659 |
GO:0000188 | inactivation of MAPK activity | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 4 | 15 |
GO:0070932 | histone H3 deacetylation | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 2 | 15 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.42e-02 | 1.00e+00 | 1.563 | 4 | 29 | 456 |
GO:0004872 | receptor activity | 4.61e-02 | 1.00e+00 | 2.537 | 2 | 4 | 116 |
GO:0048265 | response to pain | 4.65e-02 | 1.00e+00 | 4.395 | 1 | 1 | 16 |
GO:0005782 | peroxisomal matrix | 4.65e-02 | 1.00e+00 | 4.395 | 1 | 1 | 16 |
GO:0001829 | trophectodermal cell differentiation | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 2 | 17 |
GO:0007631 | feeding behavior | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 1 | 17 |
GO:0005640 | nuclear outer membrane | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 1 | 17 |
GO:0043022 | ribosome binding | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 2 | 17 |
GO:0031047 | gene silencing by RNA | 5.22e-02 | 1.00e+00 | 4.225 | 1 | 2 | 18 |
GO:0006378 | mRNA polyadenylation | 5.22e-02 | 1.00e+00 | 4.225 | 1 | 3 | 18 |
GO:0000398 | mRNA splicing, via spliceosome | 5.50e-02 | 1.00e+00 | 2.395 | 2 | 15 | 128 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 1 | 19 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 1 | 19 |
GO:0071346 | cellular response to interferon-gamma | 5.78e-02 | 1.00e+00 | 4.073 | 1 | 2 | 20 |
GO:0005720 | nuclear heterochromatin | 5.78e-02 | 1.00e+00 | 4.073 | 1 | 3 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 5.78e-02 | 1.00e+00 | 4.073 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 5.78e-02 | 1.00e+00 | 4.073 | 1 | 2 | 20 |
GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway | 6.06e-02 | 1.00e+00 | 4.003 | 1 | 1 | 21 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 6.06e-02 | 1.00e+00 | 4.003 | 1 | 2 | 21 |
GO:0007569 | cell aging | 6.06e-02 | 1.00e+00 | 4.003 | 1 | 1 | 21 |
GO:0055114 | oxidation-reduction process | 6.21e-02 | 1.00e+00 | 1.714 | 3 | 9 | 308 |
GO:0051084 | 'de novo' posttranslational protein folding | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 4 | 22 |
GO:0019722 | calcium-mediated signaling | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 1 | 22 |
GO:0030331 | estrogen receptor binding | 6.34e-02 | 1.00e+00 | 3.936 | 1 | 2 | 22 |
GO:0006821 | chloride transport | 6.62e-02 | 1.00e+00 | 3.872 | 1 | 2 | 23 |
GO:0000049 | tRNA binding | 6.62e-02 | 1.00e+00 | 3.872 | 1 | 2 | 23 |
GO:0045892 | negative regulation of transcription, DNA-templated | 6.65e-02 | 1.00e+00 | 1.672 | 3 | 17 | 317 |
GO:0044212 | transcription regulatory region DNA binding | 6.69e-02 | 1.00e+00 | 2.236 | 2 | 13 | 143 |
GO:0005622 | intracellular | 6.85e-02 | 1.00e+00 | 2.216 | 2 | 2 | 145 |
GO:0008180 | COP9 signalosome | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 6 | 24 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 4 | 24 |
GO:0016592 | mediator complex | 7.17e-02 | 1.00e+00 | 3.752 | 1 | 6 | 25 |
GO:0010827 | regulation of glucose transport | 7.17e-02 | 1.00e+00 | 3.752 | 1 | 7 | 25 |
GO:0030901 | midbrain development | 7.17e-02 | 1.00e+00 | 3.752 | 1 | 1 | 25 |
GO:0050885 | neuromuscular process controlling balance | 8.00e-02 | 1.00e+00 | 3.588 | 1 | 1 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 8.28e-02 | 1.00e+00 | 3.537 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 8.28e-02 | 1.00e+00 | 3.537 | 1 | 6 | 29 |
GO:0042752 | regulation of circadian rhythm | 8.28e-02 | 1.00e+00 | 3.537 | 1 | 5 | 29 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 8.55e-02 | 1.00e+00 | 3.489 | 1 | 3 | 30 |
GO:0008015 | blood circulation | 8.82e-02 | 1.00e+00 | 3.441 | 1 | 1 | 31 |
GO:0045454 | cell redox homeostasis | 8.82e-02 | 1.00e+00 | 3.441 | 1 | 3 | 31 |
GO:0016071 | mRNA metabolic process | 9.01e-02 | 1.00e+00 | 1.986 | 2 | 10 | 170 |
GO:0007077 | mitotic nuclear envelope disassembly | 9.09e-02 | 1.00e+00 | 3.395 | 1 | 9 | 32 |
GO:0017148 | negative regulation of translation | 9.36e-02 | 1.00e+00 | 3.351 | 1 | 5 | 33 |
GO:0000786 | nucleosome | 9.63e-02 | 1.00e+00 | 3.308 | 1 | 2 | 34 |
GO:0003712 | transcription cofactor activity | 9.63e-02 | 1.00e+00 | 3.308 | 1 | 3 | 34 |
GO:0071407 | cellular response to organic cyclic compound | 9.63e-02 | 1.00e+00 | 3.308 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 9.63e-02 | 1.00e+00 | 3.308 | 1 | 1 | 34 |
GO:0031124 | mRNA 3'-end processing | 9.90e-02 | 1.00e+00 | 3.266 | 1 | 4 | 35 |
GO:0044297 | cell body | 9.90e-02 | 1.00e+00 | 3.266 | 1 | 5 | 35 |
GO:0030521 | androgen receptor signaling pathway | 9.90e-02 | 1.00e+00 | 3.266 | 1 | 3 | 35 |
GO:0008645 | hexose transport | 1.02e-01 | 1.00e+00 | 3.225 | 1 | 8 | 36 |
GO:0030900 | forebrain development | 1.02e-01 | 1.00e+00 | 3.225 | 1 | 2 | 36 |
GO:1902476 | chloride transmembrane transport | 1.02e-01 | 1.00e+00 | 3.225 | 1 | 2 | 36 |
GO:0005201 | extracellular matrix structural constituent | 1.04e-01 | 1.00e+00 | 3.186 | 1 | 1 | 37 |
GO:0005975 | carbohydrate metabolic process | 1.05e-01 | 1.00e+00 | 1.856 | 2 | 10 | 186 |
GO:0016070 | RNA metabolic process | 1.07e-01 | 1.00e+00 | 1.841 | 2 | 10 | 188 |
GO:0006369 | termination of RNA polymerase II transcription | 1.07e-01 | 1.00e+00 | 3.147 | 1 | 5 | 38 |
GO:0043202 | lysosomal lumen | 1.10e-01 | 1.00e+00 | 3.110 | 1 | 1 | 39 |
GO:0006417 | regulation of translation | 1.10e-01 | 1.00e+00 | 3.110 | 1 | 2 | 39 |
GO:0006396 | RNA processing | 1.12e-01 | 1.00e+00 | 3.073 | 1 | 4 | 40 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.12e-01 | 1.00e+00 | 3.073 | 1 | 4 | 40 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 1.18e-01 | 1.00e+00 | 3.003 | 1 | 1 | 42 |
GO:0001047 | core promoter binding | 1.18e-01 | 1.00e+00 | 3.003 | 1 | 4 | 42 |
GO:0008217 | regulation of blood pressure | 1.18e-01 | 1.00e+00 | 3.003 | 1 | 2 | 42 |
GO:0000932 | cytoplasmic mRNA processing body | 1.20e-01 | 1.00e+00 | 2.969 | 1 | 3 | 43 |
GO:0007626 | locomotory behavior | 1.31e-01 | 1.00e+00 | 2.841 | 1 | 1 | 47 |
GO:0008203 | cholesterol metabolic process | 1.31e-01 | 1.00e+00 | 2.841 | 1 | 2 | 47 |
GO:0016032 | viral process | 1.32e-01 | 1.00e+00 | 1.239 | 3 | 30 | 428 |
GO:0007275 | multicellular organismal development | 1.32e-01 | 1.00e+00 | 1.654 | 2 | 9 | 214 |
GO:0015758 | glucose transport | 1.33e-01 | 1.00e+00 | 2.810 | 1 | 8 | 48 |
GO:0006310 | DNA recombination | 1.39e-01 | 1.00e+00 | 2.752 | 1 | 8 | 50 |
GO:0005777 | peroxisome | 1.39e-01 | 1.00e+00 | 2.752 | 1 | 2 | 50 |
GO:0006334 | nucleosome assembly | 1.41e-01 | 1.00e+00 | 2.723 | 1 | 4 | 51 |
GO:0005643 | nuclear pore | 1.41e-01 | 1.00e+00 | 2.723 | 1 | 12 | 51 |
GO:0005796 | Golgi lumen | 1.44e-01 | 1.00e+00 | 2.695 | 1 | 1 | 52 |
GO:0030203 | glycosaminoglycan metabolic process | 1.46e-01 | 1.00e+00 | 2.668 | 1 | 1 | 53 |
GO:0007218 | neuropeptide signaling pathway | 1.46e-01 | 1.00e+00 | 2.668 | 1 | 2 | 53 |
GO:0006816 | calcium ion transport | 1.46e-01 | 1.00e+00 | 2.668 | 1 | 1 | 53 |
GO:0005694 | chromosome | 1.51e-01 | 1.00e+00 | 2.614 | 1 | 4 | 55 |
GO:0006338 | chromatin remodeling | 1.51e-01 | 1.00e+00 | 2.614 | 1 | 7 | 55 |
GO:0071013 | catalytic step 2 spliceosome | 1.66e-01 | 1.00e+00 | 2.465 | 1 | 5 | 61 |
GO:0007417 | central nervous system development | 1.71e-01 | 1.00e+00 | 2.418 | 1 | 2 | 63 |
GO:0003682 | chromatin binding | 1.71e-01 | 1.00e+00 | 1.418 | 2 | 15 | 252 |
GO:0007204 | positive regulation of cytosolic calcium ion concentration | 1.74e-01 | 1.00e+00 | 2.395 | 1 | 1 | 64 |
GO:0051082 | unfolded protein binding | 1.89e-01 | 1.00e+00 | 2.266 | 1 | 5 | 70 |
GO:0030308 | negative regulation of cell growth | 1.89e-01 | 1.00e+00 | 2.266 | 1 | 3 | 70 |
GO:0010951 | negative regulation of endopeptidase activity | 1.91e-01 | 1.00e+00 | 2.246 | 1 | 2 | 71 |
GO:0016363 | nuclear matrix | 1.96e-01 | 1.00e+00 | 2.206 | 1 | 10 | 73 |
GO:0071456 | cellular response to hypoxia | 2.03e-01 | 1.00e+00 | 2.147 | 1 | 2 | 76 |
GO:0001501 | skeletal system development | 2.17e-01 | 1.00e+00 | 2.038 | 1 | 2 | 82 |
GO:0005635 | nuclear envelope | 2.20e-01 | 1.00e+00 | 2.020 | 1 | 6 | 83 |
GO:0031982 | vesicle | 2.29e-01 | 1.00e+00 | 1.952 | 1 | 2 | 87 |
GO:0020037 | heme binding | 2.31e-01 | 1.00e+00 | 1.936 | 1 | 3 | 88 |
GO:0044255 | cellular lipid metabolic process | 2.33e-01 | 1.00e+00 | 1.920 | 1 | 2 | 89 |
GO:0005737 | cytoplasm | 2.36e-01 | 1.00e+00 | 0.355 | 10 | 127 | 2633 |
GO:0000278 | mitotic cell cycle | 2.39e-01 | 1.00e+00 | 1.101 | 2 | 28 | 314 |
GO:0005506 | iron ion binding | 2.40e-01 | 1.00e+00 | 1.872 | 1 | 4 | 92 |
GO:0008017 | microtubule binding | 2.52e-01 | 1.00e+00 | 1.796 | 1 | 9 | 97 |
GO:0006457 | protein folding | 2.52e-01 | 1.00e+00 | 1.796 | 1 | 5 | 97 |
GO:0005788 | endoplasmic reticulum lumen | 2.67e-01 | 1.00e+00 | 1.695 | 1 | 4 | 104 |
GO:0031012 | extracellular matrix | 2.74e-01 | 1.00e+00 | 1.654 | 1 | 4 | 107 |
GO:0006397 | mRNA processing | 2.80e-01 | 1.00e+00 | 1.614 | 1 | 12 | 110 |
GO:0044267 | cellular protein metabolic process | 2.81e-01 | 1.00e+00 | 0.936 | 2 | 14 | 352 |
GO:0042802 | identical protein binding | 2.83e-01 | 1.00e+00 | 0.928 | 2 | 15 | 354 |
GO:0042981 | regulation of apoptotic process | 2.85e-01 | 1.00e+00 | 1.588 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 2.91e-01 | 1.00e+00 | 1.550 | 1 | 8 | 115 |
GO:0005578 | proteinaceous extracellular matrix | 2.91e-01 | 1.00e+00 | 1.550 | 1 | 4 | 115 |
GO:0003924 | GTPase activity | 3.00e-01 | 1.00e+00 | 1.501 | 1 | 7 | 119 |
GO:0006974 | cellular response to DNA damage stimulus | 3.04e-01 | 1.00e+00 | 1.477 | 1 | 11 | 121 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.09e-01 | 1.00e+00 | 0.837 | 2 | 21 | 377 |
GO:0004930 | G-protein coupled receptor activity | 3.10e-01 | 1.00e+00 | 1.441 | 1 | 2 | 124 |
GO:0000082 | G1/S transition of mitotic cell cycle | 3.12e-01 | 1.00e+00 | 1.430 | 1 | 4 | 125 |
GO:0005515 | protein binding | 3.16e-01 | 1.00e+00 | 0.193 | 14 | 198 | 4124 |
GO:0006184 | GTP catabolic process | 3.22e-01 | 1.00e+00 | 1.373 | 1 | 7 | 130 |
GO:0007267 | cell-cell signaling | 3.58e-01 | 1.00e+00 | 1.186 | 1 | 1 | 148 |
GO:0005634 | nucleus | 3.60e-01 | 1.00e+00 | 0.190 | 11 | 158 | 3246 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 3.83e-01 | 1.00e+00 | 1.065 | 1 | 18 | 161 |
GO:0005874 | microtubule | 3.87e-01 | 1.00e+00 | 1.047 | 1 | 10 | 163 |
GO:0006351 | transcription, DNA-templated | 3.99e-01 | 1.00e+00 | 0.324 | 4 | 47 | 1076 |
GO:0019221 | cytokine-mediated signaling pathway | 4.03e-01 | 1.00e+00 | 0.969 | 1 | 10 | 172 |
GO:0006412 | translation | 4.14e-01 | 1.00e+00 | 0.920 | 1 | 12 | 178 |
GO:0004842 | ubiquitin-protein transferase activity | 4.16e-01 | 1.00e+00 | 0.912 | 1 | 17 | 179 |
GO:0003713 | transcription coactivator activity | 4.24e-01 | 1.00e+00 | 0.872 | 1 | 21 | 184 |
GO:0016567 | protein ubiquitination | 4.31e-01 | 1.00e+00 | 0.841 | 1 | 14 | 188 |
GO:0005856 | cytoskeleton | 4.35e-01 | 1.00e+00 | 0.826 | 1 | 8 | 190 |
GO:0005829 | cytosol | 4.43e-01 | 1.00e+00 | 0.177 | 6 | 88 | 1787 |
GO:0005743 | mitochondrial inner membrane | 4.47e-01 | 1.00e+00 | 0.773 | 1 | 9 | 197 |
GO:0006281 | DNA repair | 4.57e-01 | 1.00e+00 | 0.730 | 1 | 24 | 203 |
GO:0030154 | cell differentiation | 4.58e-01 | 1.00e+00 | 0.723 | 1 | 5 | 204 |
GO:0044281 | small molecule metabolic process | 4.64e-01 | 1.00e+00 | 0.259 | 3 | 35 | 844 |
GO:0019899 | enzyme binding | 4.68e-01 | 1.00e+00 | 0.681 | 1 | 7 | 210 |
GO:0043231 | intracellular membrane-bounded organelle | 4.81e-01 | 1.00e+00 | 0.627 | 1 | 8 | 218 |
GO:0030198 | extracellular matrix organization | 4.86e-01 | 1.00e+00 | 0.608 | 1 | 7 | 221 |
GO:0005730 | nucleolus | 4.97e-01 | 1.00e+00 | 0.146 | 4 | 74 | 1217 |
GO:0007186 | G-protein coupled receptor signaling pathway | 4.98e-01 | 1.00e+00 | 0.556 | 1 | 4 | 229 |
GO:0003677 | DNA binding | 5.44e-01 | 1.00e+00 | 0.093 | 3 | 52 | 947 |
GO:0006508 | proteolysis | 5.49e-01 | 1.00e+00 | 0.351 | 1 | 11 | 264 |
GO:0046982 | protein heterodimerization activity | 5.50e-01 | 1.00e+00 | 0.346 | 1 | 11 | 265 |
GO:0007165 | signal transduction | 5.56e-01 | 1.00e+00 | 0.124 | 2 | 24 | 618 |
GO:0008285 | negative regulation of cell proliferation | 5.66e-01 | 1.00e+00 | 0.282 | 1 | 11 | 277 |
GO:0055085 | transmembrane transport | 6.30e-01 | 1.00e+00 | 0.033 | 1 | 13 | 329 |
GO:0006355 | regulation of transcription, DNA-templated | 6.38e-01 | 1.00e+00 | -0.086 | 2 | 31 | 715 |
GO:0007596 | blood coagulation | 6.42e-01 | 1.00e+00 | -0.010 | 1 | 13 | 339 |
GO:0006366 | transcription from RNA polymerase II promoter | 6.44e-01 | 1.00e+00 | -0.018 | 1 | 23 | 341 |
GO:0008270 | zinc ion binding | 6.47e-01 | 1.00e+00 | -0.110 | 2 | 39 | 727 |
GO:0005783 | endoplasmic reticulum | 6.85e-01 | 1.00e+00 | -0.178 | 1 | 12 | 381 |
GO:0070062 | extracellular vesicular exosome | 7.42e-01 | 1.00e+00 | -0.285 | 4 | 51 | 1641 |
GO:0005524 | ATP binding | 7.57e-01 | 1.00e+00 | -0.405 | 2 | 37 | 892 |
GO:0046872 | metal ion binding | 7.80e-01 | 1.00e+00 | -0.472 | 2 | 24 | 934 |
GO:0005887 | integral component of plasma membrane | 8.28e-01 | 1.00e+00 | -0.772 | 1 | 8 | 575 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8.62e-01 | 1.00e+00 | -0.935 | 1 | 29 | 644 |
GO:0005615 | extracellular space | 8.65e-01 | 1.00e+00 | -0.951 | 1 | 15 | 651 |
GO:0005576 | extracellular region | 8.70e-01 | 1.00e+00 | -0.977 | 1 | 15 | 663 |
GO:0016021 | integral component of membrane | 9.54e-01 | 1.00e+00 | -1.180 | 2 | 19 | 1526 |
GO:0005886 | plasma membrane | 9.79e-01 | 1.00e+00 | -1.405 | 2 | 46 | 1784 |